Metabolic reprogramming in the arsenic carcinogenesis

Area of Science:

• Environmental Health
• Cancer Biology
• Metabolomics

Background:

• Chronic arsenic exposure is associated with various cancers, but the underlying mechanisms remain unclear.
• Metabolic reprogramming is increasingly recognized as a key factor in tumorigenesis.
• Arsenic exposure alters metabolite profiles in biological samples, suggesting a link to cancer development.

Purpose of the Study:

• To review current findings on metabolic reprogramming in response to arsenic exposure.
• To explore alterations in glucose, lipid, and amino acid metabolism.
• To connect metabolic changes with arsenic-induced carcinogenesis.

Main Methods:

• Literature review of recent studies on arsenic exposure and metabolism.
• Analysis of findings related to glycolysis, lipolysis, and amino acid pathways.
• Examination of the role of oxidative stress in linking arsenic toxicity and metabolism.

Main Results:

• Arsenic exposure generally enhances glycolysis, though a "reverse Warburg effect" is observed in some in vivo models.
• Arsenic disrupts lipid metabolism by inhibiting lipolysis and affects the serine-glycine one-carbon pathway.
• Oxidative stress is a significant mechanism linking arsenic toxicity to metabolic reprogramming.

Conclusions:

• Metabolic reprogramming is a promising avenue for understanding arsenic carcinogenesis.
• Metabolic alterations may depend on arsenic dose and exposure duration.
• Further research is needed to establish causal relationships and identify conserved metabolic changes.